Finch Therapeutics Group, Inc., (FNCH) Social Stream
FINCH THERAPEUTICS GROUP INC (FNCH) Price Targets From Analysts
Use the tables below to see what analysts covering FINCH THERAPEUTICS GROUP INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-10 | 3 | $34 | $26 | $29.666 | $3.296 | 800.06% |
| 2022-03-18 | 3 | $34 | $27 | $30 | $3.296 | 810.19% |
| 2022-04-01 | 3 | $34 | $20 | $27.666 | $3.296 | 739.38% |
| 2022-04-04 | 3 | $20 | $17 | $18.5 | $3.296 | 461.29% |
| 2022-04-29 | 2 | $20 | $17 | $18.5 | $3.296 | 461.29% |
| 2022-05-16 | 3 | $17 | $11 | $14 | $3.296 | 324.76% |
| 2022-08-09 | 3 | $20 | $17 | $18 | $3.296 | 446.12% |
| 2022-08-13 | 3 | $17 | $10 | $14.666 | $3.296 | 344.96% |
| 2022-11-11 | 3 | $17 | $6 | $13.333 | $3.296 | 304.52% |
| 2023-01-24 | 3 | $17 | $3 | $10 | $3.296 | 203.4% |
| 2023-04-04 | 3 | $7 | $3 | $5 | $3.296 | 51.7% |
| 2023-05-12 | 2 | $210.21 | $90.09 | $150.15 | $3.296 | 4455.52% |
| 2023-08-21 | 2 | $90.09 | $10 | $50.045 | $3.296 | 1418.36% |
The Trend in the Analyst Price Target
FNCH's average price target has moved up $21.05 over the prior 28 months.
Over the past 30 weeks, FNCH's average upside potential has been 8,284.42%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 3 | 90.09 | 90.09 | 90.090 | 0.495 | 18100% |
| 2023-01-24 | 3 | 17.00 | 3.00 | 12.333 | 0.495 | 2391.52% |
| 2023-01-24 | 1 | 17.00 | 3.00 | 10.000 | 0.495 | 1920.2% |
| 2023-04-04 | 3 | 7.00 | 3.00 | 5.000 | 0.370 | 1251.35% |
| 2023-05-12 | 2 | 7.00 | 3.00 | 5.000 | 0.358 | 1296.65% |
FNCH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
FNCH's average broker recommendation rating improved by 0 over the prior 25 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- FINCH THERAPEUTICS GROUP INC's number of analysts covering the stock is higher than 110.09% of all US stocks.
- FINCH THERAPEUTICS GROUP INC's upside potential (average analyst target price relative to current price) is higher than 1736% of all US stocks.
- In terms of how FINCH THERAPEUTICS GROUP INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -624.37% of that group.
- In the context of Healthcare stocks, FINCH THERAPEUTICS GROUP INC's average analyst price target is greater than 677.58% of them.
Stocks similar to FINCH THERAPEUTICS GROUP INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IKNA, IPSC, and AMAM.
View All Top Stocks by Price Target
What is the outlook for FNCH? Use POWR Ratings for clearer insight into price direction.